home All News open_in_new Full Article

Revive Therapeutics Announces Extension of Proposed Private Placement

TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is extending is previously announced private placement offering of up to 30,952,381 units, at a price of $0.021 per […]


today 8 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Science
attach_file Events
attach_file Sport
attach_file Other
attach_file Science
attach_file Events
attach_file Society
attach_file Society
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Sport
attach_file Society
attach_file Economics
attach_file Events


ID: 2314740192
Add Watch Country

arrow_drop_down